{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:29:03Z","timestamp":1770524943858,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.forsciint.2024.112131","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T02:51:59Z","timestamp":1720234319000},"page":"112131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021"],"prefix":"10.1016","volume":"361","author":[{"given":"Per Ole M.","family":"Gundersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Sl\u00f8rdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Josefsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2024.112131_bib1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, European drug report 2023: Trends and developments. \u3008https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023_en\u3009, 2023 (accessed 24 February 2024)."},{"key":"10.1016\/j.forsciint.2024.112131_bib2","unstructured":"United Nations Office on Drugs and Crime, Early Warning Advisory on New Psychoactive Substances. \u3008https:\/\/www.unodc.org\/LSS\/Page\/NPS\u3009, 2023 (accessed 19 November 2023)."},{"key":"10.1016\/j.forsciint.2024.112131_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/jat\/bkz030","article-title":"HighResNPS.com: an online crowd-sourced HR-MS database for suspect and non-targeted screening of new psychoactive substances","volume":"43","author":"Mardal","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113936","article-title":"Comprehensive UHPLC-HR-MSE screening workflow optimized for use in routine laboratory medicine: four workflows in one analytical method","volume":"196","author":"Mardal","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2024.112131_bib5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jat\/bkaa028","article-title":"Identification of new psychoactive substances in seized material Using UHPLC\u2013QTOF-MS and an online mass spectral database","volume":"44","author":"von C\u00fcpper","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242224","article-title":"How to perform spectrum-based LC-HR-MS screening for more than 1,000 NPS with HighResNPS consensus fragment ions","volume":"15","author":"Davidsen","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.forsciint.2024.112131_bib7","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.1021\/acs.analchem.3c03451","article-title":"Identification of emerging novel psychoactive substances by retrospective analysis of population-scale mass spectrometry data sets","volume":"95","author":"Skinnider","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.forsciint.2024.112131_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.868532","article-title":"A new strategy for efficient retrospective data analyses for designer benzodiazepines in large LC-HRMS datasets","volume":"10","author":"Pan","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.forsciint.2024.112131_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.13786","article-title":"Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis","author":"Axelsson","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/dta.2263","article-title":"Application of a screening method for fentanyl and its analogues using UHPLC-QTOF-MS with data-independent acquisition (DIA) in MSE mode and retrospective analysis of authentic forensic blood samples","volume":"10","author":"Noble","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2024.112131_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jat\/bky039","article-title":"A case study involving U-47700, diclazepam and flubromazepam\u2014application of retrospective analysis of HRMS data","volume":"42","author":"Partridge","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.forsciint.2019.04.030","article-title":"Toxic lifespan of the synthetic opioid U-47,700 in Finland verified by re-analysis of UPLC-TOF-MS data","volume":"300","author":"Kriikku","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2024.112131_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110274","article-title":"Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018","volume":"311","author":"Gundersen","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2024.112131_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339035","article-title":"Development of a single retention time prediction model integrating multiple liquid chromatography systems: application to new psychoactive substances","volume":"1184","author":"Pasin","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.forsciint.2024.112131_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13181-011-0159-1","article-title":"Seizures and hyponatremia related to ethcathinone and methylone poisoning","volume":"8","author":"Boulanger-Gobeil","year":"2012","journal-title":"J. Med Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib16","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, Europol 2008 Annual Report on the implementation of Council Decision 2005\/387\/JHA, Annex 2: New psychoactive substances reported to the EMCDDA and Europol for the first time in 2008 under the terms of Council Decision 2005\/387\/JHA. \u3008https:\/\/www.emcdda.europa.eu\/html.cfm\/index132901EN.html_en\u3009, 2008 (accessed 19 November 2023)."},{"key":"10.1016\/j.forsciint.2024.112131_bib17","series-title":"TIHKAL: The continuation","article-title":"Transform press Berkeley","author":"Shulgin","year":"1997"},{"key":"10.1016\/j.forsciint.2024.112131_bib18","first-page":"245","article-title":"New psychoactive substances in Poland: An overview of psychodysleptics (lysergamides and tryptamines)","author":"S\u0142onina","year":"2018","journal-title":"World Sci. N."},{"key":"10.1016\/j.forsciint.2024.112131_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jat\/bkab062","article-title":"Can the intake of a synthetic tryptamine be detected only by blood plasma analysis? A clinical toxicology case involving 4-HO-MET","volume":"46","author":"Wagmann","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib20","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, Europol 2009 Annual Report on the implementation of Council Decision 2005\/387\/JHA, Annex 2: New psychoactive substances reported to the EMCDDA and Europol for the first time in 2009 under the terms of Council Decision 2005\/387\/JHA. \u3008https:\/\/www.emcdda.europa.eu\/html.cfm\/index132910EN.html_en\u3009, 2009 (accessed 19 November 2023)."},{"key":"10.1016\/j.forsciint.2024.112131_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jat\/bkv089","article-title":"A fatality related to two novel hallucinogenic compounds: 4-methoxyphencyclidine and 4-hydroxy-N-methyl-N-ethyltryptamine","volume":"39","author":"McIntyre","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib22","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, Europol 2014 Annual Report on the implementation of Council Decision 2005\/387\/JHA. \u3008https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/1018\/TDAN15001ENN.pdf\u3009, 2014 (accessed 19 November 2023)."},{"key":"10.1016\/j.forsciint.2024.112131_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1145140","article-title":"Metabolic stability and metabolite profiling of emerging synthetic cathinones","volume":"14","author":"Lopes","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.forsciint.2024.112131_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jat\/bky099","article-title":"A fatality involving furanylfentanyl and MMMP, with presumptive identification of three MMMP metabolites in urine","volume":"43","author":"Nash","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12024-009-9130-8","article-title":"The influence of putrefaction and sample storage on post-mortem toxicology results","volume":"6","author":"Butzbach","year":"2010","journal-title":"Forensic Sci., Med., Pathol."},{"key":"10.1016\/j.forsciint.2024.112131_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/20961790.2018.1460063","article-title":"Fatalities caused by novel opioids: a review","volume":"4","author":"Drummer","year":"2019","journal-title":"Forensic Sci. Res."},{"key":"10.1016\/j.forsciint.2024.112131_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jat\/bkab117","article-title":"A forward-thinking approach to addressing the new synthetic opioid 2-benzylbenzimidazole nitazene analogs by liquid chromatography-tandem quadrupole mass spectrometry (LC-QQQ-MS)","volume":"46","author":"Walton","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib28","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00204-022-03276-4","article-title":"Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole \u2018nitazene\u2019 synthetic opioid","volume":"96","author":"Vandeputte","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.forsciint.2024.112131_bib29","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, European drug report 2022: Trends and developments. \u3008https:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2022_en\u3009, 2022 (accessed 24 February 2024)."},{"key":"10.1016\/j.forsciint.2024.112131_bib30","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1093\/jat\/bky080","article-title":"A wolf in sheep\u2019s clothing","volume":"43","author":"Brede","year":"2018","journal-title":"J. Anal. Toxicol."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073824002123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073824002123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:37:29Z","timestamp":1722645449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073824002123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"alternative-id":["S0379073824002123"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2024.112131","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2024.112131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112131"}}